Anti-CCL2 (Carlumab) -MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA
Anti-CCL2 (Carlumab) -MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA is an antibody-drug conjugate (ADC) consisting of the humanized anti-CCL2 (chemokine ligand 2) antibody Carlumab conjugated with the linker MC-Vc-PAB-DMEA-PEG2 and the DNA alkylator Duocarmycin SA (HY-12456). Anti-CCL2 (Carlumab) -MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA can be used in cancer research[1][2].
Product Specifications
UNSPSC
12352203
Target
ADC Payload; Antibiotic; Antibody-Drug Conjugates (ADCs) ; Apoptosis; CCR; DNA Alkylator/Crosslinker
Related Pathways
Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Cell Cycle/DNA Damage; GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Anti-CCL2(Carlumab)-MC-Vc-PAB-DMEA-PEG2-DuocarmycinSA]
References & Citations
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
CCR2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Tyrosinase (T311), CF640R conjugate, 0.1mg/mL
Cytokeratin, HMW (AE-3), CF740 conjugate, 0.1mg/mL
